Elicio Therapeutics, Inc.
ELTX
$2.18
-$0.17-7.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.22M | -11.82M | -7.72M | -10.08M | -10.56M |
| Total Depreciation and Amortization | 283.00K | 289.00K | 286.00K | 283.00K | 281.00K |
| Total Amortization of Deferred Charges | 60.00K | 68.00K | 217.00K | -35.00K | 0.00 |
| Total Other Non-Cash Items | -1.55M | 1.85M | -1.02M | 5.82M | 1.68M |
| Change in Net Operating Assets | 1.26M | -2.03M | 1.44M | -4.18M | -351.00K |
| Cash from Operations | -8.17M | -11.65M | -6.80M | -11.09M | -8.95M |
| Capital Expenditure | -- | -- | -16.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -16.00K | -- | -- |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 9.87M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.35M | 8.09M | 4.86M | 9.57M | 2.97M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -839.00K | -61.00K | -- | -- | -900.00K |
| Cash from Financing | 16.51M | 8.03M | 4.86M | 9.57M | 11.93M |
| Foreign Exchange rate Adjustments | -4.00K | 5.00K | -96.00K | 39.00K | 74.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.34M | -3.61M | -2.05M | -1.48M | 3.06M |